Benzinga | Jul 20, 2021 12:07PM EDT

SVB Leerink Maintains Market Perform on Abiomed, Lowers Price Target to $335

SVB Leerink analyst Danielle Antalffy maintains Abiomed (NASDAQ:ABMD) with a Market Perform and lowers the price target from $355 to $335.